<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-03T15:52:43Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/6AFFE52F-2EC2-4E85-BBE4-7481968D28A0" ns1:id="6AFFE52F-2EC2-4E85-BBE4-7481968D28A0"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/65EAC07B-0B87-4CD5-9A0B-D12BCF975ECE" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/65EAC07B-0B87-4CD5-9A0B-D12BCF975ECE" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2018-07-30T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/A6342E93-4A7C-4BE7-9BE8-296FDB2D5EE1" ns1:rel="FUND" ns1:start="2017-07-31T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">133056</ns2:identifier></ns2:identifiers><ns2:title>Next Generation Catheter</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Feasibility Studies</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>Each year, over 100 million people around the world need to use a urinary catheter. However, they currently cause infections resulting in around 2,000 deaths in the UK each year and &amp;pound;83,000 in treatment costs for a typical hospital. We have developed a technology that will significantly reduce catheter infections, without the use of pharmaceuticals. With the ageing of the population in the UK and around the world, the number of people requiring a catheter is rising. By reducing the rate of infection, thousands of patients a year will suffer less and require fewer inconvenient catheter replacements, leading to an all round better, more comfortable experience. This reduction in infection will also save a typical hospital tens of thousands of pounds a year as well as reducing overcrowding, a prominent issue at present. By reducing the need for antibiotic treatment, we will also significantly reduce the spread of antibiotic resistant bacteria. We are a mico entity based in England, founded in July 2015</ns2:abstractText></ns2:project>